cached image

Serge Gauthier, MD, FRCPC - Publications

Affiliations: 
Neurology & Neurosurgery, Psychiatry, Medicine McGill University, Montreal, QC, Canada 
Area:
http://www.researchprofiles.collexis.com/jad/expert.asp?u_id=102
Website:
http://aging.mcgill.ca/gauthier.htm

116 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Mathotaarachchi S, Wang S, Shin M, Pascoal TA, Benedet AL, Kang MS, Beaudry T, Fonov VS, Gauthier S, Labbe A, Rosa-Neto P. VoxelStats: A MATLAB Package for Multi-Modal Voxel-Wise Brain Image Analysis. Frontiers in Neuroinformatics. 10: 20. PMID 27378902 DOI: 10.3389/fninf.2016.00020  0.76
2016 Schoemaker D, Poirier J, Escobar S, Gauthier S, Pruessner J. Selective familiarity deficits in otherwise cognitively intact aging individuals with genetic risk for Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 2: 132-9. PMID 27239534 DOI: 10.1016/j.dadm.2015.11.007  0.76
2016 Gauthier S, Rosa-Neto P, Kass JS. Ethical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients. Continuum (Minneapolis, Minn.). 22: 615-8. PMID 27042911 DOI: 10.1212/CON.0000000000000306  0.76
2016 Winblad B, Amouyel P, Andrieu S, Ballard C, Brayne C, Brodaty H, Cedazo-Minguez A, Dubois B, Edvardsson D, Feldman H, Fratiglioni L, Frisoni GB, Gauthier S, Georges J, Graff C, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. The Lancet. Neurology. 15: 455-532. PMID 26987701 DOI: 10.1016/S1474-4422(16)00062-4  0.76
2016 Schoemaker D, Buss C, Head K, Sandman CA, Davis EP, Chakravarty MM, Gauthier S, Pruessner J. Hippocampus and amygdala volumes from magnetic resonance images in children: Assessing accuracy of FreeSurfer and FSL against manual segmentation. Neuroimage. PMID 26824403 DOI: 10.1016/j.neuroimage.2016.01.038  0.76
2015 Benedet AL, Labbe A, Lemay P, Zimmer ER, Pascoal TA, Leuzy A, Mathotaarachchi S, Mohades S, Shin M, Dionne-Laporte A, Beaudry T, Picard C, Gauthier S, Poirier J, Rouleau G, et al. Epistasis analysis links immune cascades and cerebral amyloidosis. Journal of Neuroinflammation. 12: 227. PMID 26626881 DOI: 10.1186/s12974-015-0436-z  0.76
2015 Cloutier S, Chertkow H, Kergoat MJ, Gauthier S, Belleville S. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. 47: 901-13. PMID 26401770 DOI: 10.3233/JAD-142910  0.76
2015 Gordon MF, Lenderking WR, Duhig A, Chandler J, Lundy JJ, Miller DS, Piault-Louis E, Doody RS, Galasko D, Gauthier S, Frank L. Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 26079412 DOI: 10.1016/j.jalz.2015.04.008  0.76
2015 Gauthier S, Proaño JV, Jia J, Froelich L, Vester JC, Doppler E. Cerebrolysin in mild-to-moderate Alzheimer's disease: a meta-analysis of randomized controlled clinical trials. Dementia and Geriatric Cognitive Disorders. 39: 332-47. PMID 25832905 DOI: 10.1159/000377672  0.76
2015 R Zimmer E, Parent MJ, Leuzy A, Aliaga A, Aliaga A, Moquin L, S Schirrmacher E, Soucy JP, Skelin I, Gratton A, Gauthier S, Rosa-Neto P. Imaging in vivo glutamate fluctuations with [(11)C]ABP688: a GLT-1 challenge with ceftriaxone. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 35: 1169-74. PMID 25806702 DOI: 10.1038/jcbfm.2015.35  0.76
2015 Leuzy A, Zimmer ER, Dubois J, Pruessner J, Cooperman C, Soucy JP, Kostikov A, Schirmaccher E, Désautels R, Gauthier S, Rosa-Neto P. In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD. Brain Structure & Function. PMID 25596865 DOI: 10.1007/s00429-014-0978-3  0.76
2015 Cummings J, Mintzer J, Brodaty H, Sano M, Banerjee S, Devanand DP, Gauthier S, Howard R, Lanctôt K, Lyketsos CG, Peskind E, Porsteinsson AP, Reich E, Sampaio C, Steffens D, et al. Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition. International Psychogeriatrics / Ipa. 27: 7-17. PMID 25311499 DOI: 10.1017/S1041610214001963  0.76
2015 Bier N, Grenier S, Brodeur C, Gauthier S, Gilbert B, Hudon C, Lepage É, Ouellet MC, Viscogliosi C, Belleville S. Measuring the impact of cognitive and psychosocial interventions in persons with mild cognitive impairment with a randomized single-blind controlled trial: rationale and design of the MEMO+ study. International Psychogeriatrics / Ipa. 27: 511-25. PMID 25268968 DOI: 10.1017/S1041610214001902  0.76
2014 Gauthier S, Schlaefke S. Efficacy and tolerability of Ginkgo biloba extract EGb 761® in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials. Clinical Interventions in Aging. 9: 2065-77. PMID 25506211 DOI: 10.2147/CIA.S72728  0.76
2014 Zimmer ER, Leuzy A, Gauthier S, Rosa-Neto P. Developments in Tau PET Imaging. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 41: 547-53. PMID 25424608 DOI: 10.1017/cjn.2014.15  0.76
2014 Tourian L, Margolese HC, Gauthier S. Donepezil-associated mania in two patients who were using donepezil without a prescription. Journal of Clinical Psychopharmacology. 34: 753-5. PMID 25203467 DOI: 10.1097/JCP.0000000000000215  0.76
2014 Zimmer ER, Parent MJ, Cuello AC, Gauthier S, Rosa-Neto P. MicroPET imaging and transgenic models: a blueprint for Alzheimer's disease clinical research. Trends in Neurosciences. 37: 629-41. PMID 25151336 DOI: 10.1016/j.tins.2014.07.002  0.76
2014 Schoemaker D, Gauthier S, Pruessner JC. Recollection and familiarity in aging individuals with mild cognitive impairment and Alzheimer's disease: a literature review. Neuropsychology Review. 24: 313-31. PMID 25115809 DOI: 10.1007/s11065-014-9265-6  0.76
2014 Hye A, Riddoch-Contreras J, Baird AL, Ashton NJ, Bazenet C, Leung R, Westman E, Simmons A, Dobson R, Sattlecker M, Lupton M, Lunnon K, Keohane A, Ward M, Pike I, ... ... Gauthier S, et al. Plasma proteins predict conversion to dementia from prodromal disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 799-807.e2. PMID 25012867 DOI: 10.1016/j.jalz.2014.05.1749  0.76
2014 Zimmer ER, Leuzy A, Benedet AL, Breitner J, Gauthier S, Rosa-Neto P. Tracking neuroinflammation in Alzheimer's disease: the role of positron emission tomography imaging. Journal of Neuroinflammation. 11: 120. PMID 25005532 DOI: 10.1186/1742-2094-11-120  0.76
2014 Leuzy A, Zimmer ER, Heurling K, Rosa-Neto P, Gauthier S. Use of amyloid PET across the spectrum of Alzheimer's disease: clinical utility and associated ethical issues. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 21: 143-8. PMID 24919109 DOI: 10.3109/13506129.2014.926267  0.76
2014 Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R, Cappa S, Crutch S, Engelborghs S, Frisoni GB, Fox NC, et al. Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria. The Lancet. Neurology. 13: 614-29. PMID 24849862 DOI: 10.1016/S1474-4422(14)70090-0  0.76
2014 Robert PH, König A, Amieva H, Andrieu S, Bremond F, Bullock R, Ceccaldi M, Dubois B, Gauthier S, Kenigsberg PA, Nave S, Orgogozo JM, Piano J, Benoit M, Touchon J, et al. Recommendations for the use of Serious Games in people with Alzheimer's Disease, related disorders and frailty. Frontiers in Aging Neuroscience. 6: 54. PMID 24715864 DOI: 10.3389/fnagi.2014.00054  0.76
2014 Zimmer ER, Leuzy A, Bhat V, Gauthier S, Rosa-Neto P. In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals. Translational Neurodegeneration. 3: 6. PMID 24628994 DOI: 10.1186/2047-9158-3-6  0.76
2014 Wimo A, Ballard C, Brayne C, Gauthier S, Handels R, Jones RW, Jonsson L, Khachaturian AS, Kramberger M. Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria. Journal of Internal Medicine. 275: 304-16. PMID 24605810 DOI: 10.1111/joim.12167  0.76
2014 Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L. Mild cognitive impairment: a concept in evolution. Journal of Internal Medicine. 275: 214-28. PMID 24605806 DOI: 10.1111/joim.12190  0.76
2014 Belleville S, Gauthier S, Lepage E, Kergoat MJ, Gilbert B. Predicting decline in mild cognitive impairment: a prospective cognitive study. Neuropsychology. 28: 643-52. PMID 24588699 DOI: 10.1037/neu0000063  0.76
2014 Wu L, Soder RB, Schoemaker D, Carbonnell F, Sziklas V, Rowley J, Mohades S, Fonov V, Bellec P, Dagher A, Shmuel A, Jia J, Gauthier S, Rosa-Neto P. Resting state executive control network adaptations in amnestic mild cognitive impairment. Journal of Alzheimer's Disease : Jad. 40: 993-1004. PMID 24583406 DOI: 10.3233/JAD-131574  0.76
2014 Leuzy A, Zimmer ER, Bhat V, Rosa-Neto P, Gauthier S. Imaging biomarkers for amyloid: a new generation of probes and what lies ahead. International Psychogeriatrics / Ipa. 26: 703-7. PMID 24524685 DOI: 10.1017/S1041610214000118  0.76
2014 Jia J, Zhou A, Wei C, Jia X, Wang F, Li F, Wu X, Mok V, Gauthier S, Tang M, Chu L, Zhou Y, Zhou C, Cui Y, Wang Q, et al. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 439-47. PMID 24418053 DOI: 10.1016/j.jalz.2013.09.008  0.76
2014 Gauthier S, Leuzy A, Rosa-Neto P. How can we improve transfer of outcomes from randomized clinical trials to clinical practice with disease-modifying drugs in Alzheimer's disease? Neuro-Degenerative Diseases. 13: 197-9. PMID 23942173 DOI: 10.1159/000353748  0.76
2014 Leuzy A, Zimmer ER, Gauthier S, Rosa-Neto P. Amyloid imaging in Alzheimer's disease: A potential new era of personalized medicine? Translational Neuroscience. 5: 51-56. DOI: 10.2478/s13380-014-0205-y  0.76
2014 Schilling LP, Leuzy A, Zimmer ER, Gauthier S, Rosa-Neto P. Nonamyloid PET biomarkers and alzheimer's disease: Current and future perspectives Future Neurology. 9: 597-613. DOI: 10.2217/fnl.14.40  0.76
2014 Souffir V, Gauthier S. A new clinical method for psychosis | Une nouvelle méthode clinique pour les psychoses Revue Francaise De Psychanalyse. 78: 829-846.  0.76
2013 Masellis M, Sherborn K, Neto P, Sadovnick DA, Hsiung GY, Black SE, Prasad S, Williams M, Gauthier S. Early-onset dementias: diagnostic and etiological considerations. Alzheimer's Research & Therapy. 5: S7. PMID 24565469 DOI: 10.1186/alzrt197  0.76
2013 Patterson C, Gauthier S. Diagnosis and treatment of dementia: the fourth canadian consensus conference. Alzheimer's Research & Therapy. 5: S1. PMID 24565164 DOI: 10.1186/alzrt196  0.76
2013 Gauthier S, Rosa-Neto P. Dementia: Disclosure of results to participants in dementia research. Nature Reviews. Neurology. 9: 608-9. PMID 24145370 DOI: 10.1038/nrneurol.2013.213  0.76
2013 Rowley J, Fonov V, Wu O, Eskildsen SF, Schoemaker D, Wu L, Mohades S, Shin M, Sziklas V, Cheewakriengkrai L, Shmuel A, Dagher A, Gauthier S, Rosa-Neto P. White matter abnormalities and structural hippocampal disconnections in amnestic mild cognitive impairment and Alzheimer's disease. Plos One. 8: e74776. PMID 24086371 DOI: 10.1371/journal.pone.0074776  0.76
2013 Palmour N, Vanderbyl BL, Zimmerman E, Gauthier S, Racine E. Alzheimer's disease dietary supplements in websites. Hec Forum : An Interdisciplinary Journal On Hospitals' Ethical and Legal Issues. 25: 361-82. PMID 23765585 DOI: 10.1007/s10730-013-9217-1  0.76
2013 Rive B, Gauthier S, Costello S, Marre C, François C. Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's disease. Cns Drugs. 27: 573-82. PMID 23765561 DOI: 10.1007/s40263-013-0074-x  0.76
2013 Gauthier S, Robillard A, Cohen S, Black S, Sampalis J, Colizza D, de Takacsy F, Schecter R. Real-life effectiveness and tolerability of the rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease: the EMBRACE study. Current Medical Research and Opinion. 29: 989-1000. PMID 23647369 DOI: 10.1185/03007995.2013.802230  0.76
2013 Gauthier S, Leuzy A, Racine E, Rosa-Neto P. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues. Progress in Neurobiology. 110: 102-13. PMID 23578568 DOI: 10.1016/j.pneurobio.2013.01.003  0.76
2013 Herrmann N, Gauthier S, Boneva N, Lemming OM. A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease. International Psychogeriatrics / Ipa. 25: 919-27. PMID 23472619 DOI: 10.1017/S1041610213000239  0.76
2013 Arrighi HM, Gélinas I, McLaughlin TP, Buchanan J, Gauthier S. Longitudinal changes in functional disability in Alzheimer's disease patients. International Psychogeriatrics / Ipa. 25: 929-37. PMID 23406898 DOI: 10.1017/S1041610212002360  0.76
2013 Cheewakriengkrai L, Gauthier S. A 10-year perspective on donepezil. Expert Opinion On Pharmacotherapy. 14: 331-8. PMID 23316713 DOI: 10.1517/14656566.2013.760543  0.76
2013 Forlini C, Gauthier S, Racine E. Should physicians prescribe cognitive enhancers to healthy individuals? Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 185: 1047-50. PMID 23251020 DOI: 10.1503/cmaj.121508  0.76
2013 Dubois B, Gauthier S, Cummings J. The utility of the new research diagnostic criteria for Alzheimer's disease. International Psychogeriatrics / Ipa. 25: 175-7. PMID 23148941 DOI: 10.1017/S1041610212002098  0.76
2013 O'Brien JT. Introduction. International Psychogeriatrics / Ipa. 25: 174-5. PMID 23146388 DOI: 10.1017/S1041610212001652  0.76
2013 Gauthier S, Molinuevo JL. Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 326-31. PMID 23110864 DOI: 10.1016/j.jalz.2011.11.005  0.76
2013 Clément F, Gauthier S, Belleville S. Executive functions in mild cognitive impairment: emergence and breakdown of neural plasticity. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 49: 1268-79. PMID 22841389 DOI: 10.1016/j.cortex.2012.06.004  0.76
2013 Holthoff V, Ferris S, Gauthier S, Ihl R, Robert P, Winblad B, Sternberg K, Tennigkeit F. Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study. International Journal of Geriatric Psychiatry. 28: 164-72. PMID 22492589 DOI: 10.1002/gps.3805  0.76
2012 Gauthier S, Patterson C, Chertkow H, Gordon M, Herrmann N, Rockwood K, Rosa-Neto P, Soucy JP. 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: S1-8. PMID 23073396  0.76
2012 Wu L, Rosa-Neto P, Hsiung GY, Sadovnick AD, Masellis M, Black SE, Jia J, Gauthier S. Early-onset familial Alzheimer's disease (EOFAD). The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: 436-45. PMID 22728850  0.76
2012 Rainville C, Lepage E, Gauthier S, Kergoat MJ, Belleville S. Executive function deficits in persons with mild cognitive impairment: a study with a Tower of London task. Journal of Clinical and Experimental Neuropsychology. 34: 306-24. PMID 22235943 DOI: 10.1080/13803395.2011.639298  0.76
2012 Peters F, Ergis AM, Gauthier S, Dieudonné B, Verny M, Jolicoeur P, Belleville S. Abnormal temporal dynamics of visual attention in Alzheimer's disease and in dementia with Lewy bodies. Neurobiology of Aging. 33: 1012.e1-10. PMID 22130206 DOI: 10.1016/j.neurobiolaging.2011.10.019  0.76
2012 Ihl R, Ferris S, Robert P, Winblad B, Gauthier S, Tennigkeit F. Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease. International Journal of Geriatric Psychiatry. 27: 15-21. PMID 21384431 DOI: 10.1002/gps.2679  0.76
2011 Aisen PS, Gauthier S, Ferris SH, Saumier D, Haine D, Garceau D, Duong A, Suhy J, Oh J, Lau WC, Sampalis J. Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study). Archives of Medical Science : Ams. 7: 102-11. PMID 22291741 DOI: 10.5114/aoms.2011.20612  0.76
2011 Jones R, Wilkinson D, Lopez OL, Cummings J, Waldemar G, Zhang R, Mackell J, Gauthier S. Collaborative research between academia and industry using a large clinical trial database: a case study in Alzheimer's disease. Trials. 12: 233. PMID 22029822 DOI: 10.1186/1745-6215-12-233  0.76
2011 Vellas B, Aisen PS, Sampaio C, Carrillo M, Scheltens P, Scherrer B, Frisoni GB, Weiner M, Schneider L, Gauthier S, Gispen-de Wied CC, Hendrix S, Feldman H, Cedarbaum J, Petersen R, et al. Prevention trials in Alzheimer's disease: an EU-US task force report. Progress in Neurobiology. 95: 594-600. PMID 21925234 DOI: 10.1016/j.pneurobio.2011.08.014  0.76
2011 Holthoff VA, Ferris S, Ihl R, Robert P, Winblad B, Gauthier S, Sternberg K, Tennigkeit F. Validation of the relevant outcome scale for Alzheimer's disease: a novel multidomain assessment for daily medical practice. Alzheimer's Research & Therapy. 3: 27. PMID 21914212 DOI: 10.1186/alzrt89  0.76
2011 Villeneuve S, Massoud F, Bocti C, Gauthier S, Belleville S. The nature of episodic memory deficits in MCI with and without vascular burden. Neuropsychologia. 49: 3027-35. PMID 21763333 DOI: 10.1016/j.neuropsychologia.2011.07.001  0.76
2011 Belleville S, Clément F, Mellah S, Gilbert B, Fontaine F, Gauthier S. Training-related brain plasticity in subjects at risk of developing Alzheimer's disease. Brain : a Journal of Neurology. 134: 1623-34. PMID 21427462 DOI: 10.1093/brain/awr037  0.76
2010 Winblad B, Gauthier S, Aström D, Stender K. Memantine benefits functional abilities in moderate to severe Alzheimer's disease. The Journal of Nutrition, Health & Aging. 14: 770-4. PMID 21085908 DOI: 10.1007/s12603-010-0122-x  0.76
2010 Lopez OL, Schwam E, Cummings J, Gauthier S, Jones R, Wilkinson D, Waldemar G, Zhang R, Schindler R. Predicting cognitive decline in Alzheimer's disease: an integrated analysis. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 6: 431-9. PMID 21044773 DOI: 10.1016/j.jalz.2010.04.003  0.76
2010 Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Meguro K, O'Brien J, et al. Revising the definition of Alzheimer's disease: a new lexicon. The Lancet. Neurology. 9: 1118-27. PMID 20934914 DOI: 10.1016/S1474-4422(10)70223-4  0.76
2010 Farlow MR, Grossberg G, Gauthier S, Meng X, Olin JT. The ACTION study: methodology of a trial to evaluate safety and efficacy of a higher dose rivastigmine transdermal patch in severe Alzheimer's disease. Current Medical Research and Opinion. 26: 2441-7. PMID 20828359 DOI: 10.1185/03007995.2010.513849  0.76
2010 Robert P, Ferris S, Gauthier S, Ihl R, Winblad B, Tennigkeit F. Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? Alzheimer's Research & Therapy. 2: 24. PMID 20796301 DOI: 10.1186/alzrt48  0.76
2010 Gauthier S, Lopez OL, Waldemar G, Jones RW, Cummings J, Zhang R, Schindler R, Schwam E. Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease. International Psychogeriatrics / Ipa. 22: 973-83. PMID 20534179 DOI: 10.1017/S1041610210000888  0.76
2010 Black SE, Gauthier S, Dalziel W, Keren R, Correia J, Hew H, Binder C. Canadian Alzheimer's disease caregiver survey: baby-boomer caregivers and burden of care. International Journal of Geriatric Psychiatry. 25: 807-13. PMID 20029824 DOI: 10.1002/gps.2421  0.76
2010 Davidson JE, Irizarry MC, Bray BC, Wetten S, Galwey N, Gibson R, Borrie M, Delisle R, Feldman HH, Hsiung GY, Fornazzari L, Gauthier S, Guzman D, Loy-English I, Keren R, et al. An exploration of cognitive subgroups in Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 16: 233-43. PMID 19958568 DOI: 10.1017/S1355617709991160  0.76
2010 Bélanger S, Belleville S, Gauthier S. Inhibition impairments in Alzheimer's disease, mild cognitive impairment and healthy aging: effect of congruency proportion in a Stroop task. Neuropsychologia. 48: 581-90. PMID 19879885 DOI: 10.1016/j.neuropsychologia.2009.10.021  0.76
2009 Brambati SM, Belleville S, Kergoat MJ, Chayer C, Gauthier S, Joubert S. Single- and multiple-domain amnestic mild cognitive impairment: two sides of the same coin? Dementia and Geriatric Cognitive Disorders. 28: 541-9. PMID 20016185 DOI: 10.1159/000255240  0.76
2009 Wilkinson D, Schindler R, Schwam E, Waldemar G, Jones RW, Gauthier S, Lopez OL, Cummings J, Xu Y, Feldman HH. Effectiveness of donepezil in reducing clinical worsening in patients with mild-to-moderate alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 28: 244-51. PMID 19786776 DOI: 10.1159/000241877  0.76
2009 Ferris S, Ihl R, Robert P, Winblad B, Gatz G, Tennigkeit F, Gauthier S. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 375-9. PMID 19751916 DOI: 10.1016/j.jalz.2009.04.1236  0.76
2009 Ferris S, Ihl R, Robert P, Winblad B, Gatz G, Tennigkeit F, Gauthier S. Treatment effects of Memantine on language in moderate to severe Alzheimer's disease patients. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 369-74. PMID 19751915 DOI: 10.1016/j.jalz.2009.05.604  0.76
2009 Khachaturian ZS, Camí J, Andrieu S, Avila J, Boada Rovira M, Breteler M, Froelich L, Gauthier S, Gómez-Isla T, Khachaturian AS, Kuller LH, Larson EB, Lopez OL, Martinez-Lage JM, Petersen RC, et al. Creating a transatlantic research enterprise for preventing Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 361-6. PMID 19560106 DOI: 10.1016/j.jalz.2009.05.158  0.76
2009 Ballard CG, Gauthier S, Cummings JL, Brodaty H, Grossberg GT, Robert P, Lyketsos CG. Management of agitation and aggression associated with Alzheimer disease. Nature Reviews. Neurology. 5: 245-55. PMID 19488082 DOI: 10.1038/nrneurol.2009.39  0.76
2009 Gauthier S, Poirier J. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease? Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 147-8. PMID 19328447 DOI: 10.1016/j.jalz.2009.01.007  0.76
2009 Villeneuve S, Belleville S, Massoud F, Bocti C, Gauthier S. Impact of vascular risk factors and diseases on cognition in persons with mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 27: 375-81. PMID 19321941 DOI: 10.1159/000209965  0.76
2009 Hudon C, Belleville S, Gauthier S. The assessment of recognition memory using the Remember/Know procedure in amnestic mild cognitive impairment and probable Alzheimer's disease. Brain and Cognition. 70: 171-9. PMID 19250730 DOI: 10.1016/j.bandc.2009.01.009  0.76
2008 Letenneur L, Pérès K, Fleury H, Garrigue I, Barberger-Gateau P, Helmer C, Orgogozo JM, Gauthier S, Dartigues JF. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. Plos One. 3: e3637. PMID 18982063 DOI: 10.1371/journal.pone.0003637  0.76
2008 Gauthier S, Poirier J. Current and future management of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: S48-50. PMID 18632000 DOI: 10.1016/j.jalz.2007.11.010  0.76
2008 Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, et al. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 156-63. PMID 18631960 DOI: 10.1016/j.jalz.2008.03.005  0.76
2008 Hsiung GY, Alipour S, Jacova C, Grand J, Gauthier S, Black SE, Bouchard RW, Kertesz A, Loy-English I, Hogan DB, Rockwood K, Feldman HH. Transition from cognitively impaired not demented to Alzheimer's disease: an analysis of changes in functional abilities in a dementia clinic cohort. Dementia and Geriatric Cognitive Disorders. 25: 483-90. PMID 18417973 DOI: 10.1159/000126499  0.76
2008 Hudon C, Belleville S, Gauthier S. The association between depressive and cognitive symptoms in amnestic mild cognitive impairment. International Psychogeriatrics / Ipa. 20: 710-23. PMID 18397547 DOI: 10.1017/S1041610208007114  0.76
2008 Belleville S, Bherer L, Lepage E, Chertkow H, Gauthier S. Task switching capacities in persons with Alzheimer's disease and mild cognitive impairment. Neuropsychologia. 46: 2225-33. PMID 18374374 DOI: 10.1016/j.neuropsychologia.2008.02.012  0.76
2008 Winblad B, Gauthier S, Scinto L, Feldman H, Wilcock GK, Truyen L, Mayorga AJ, Wang D, Brashear HR, Nye JS. Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology. 70: 2024-35. PMID 18322263 DOI: 10.1212/01.wnl.0000303815.69777.26  0.76
2008 Clément F, Belleville S, Gauthier S. Cognitive complaint in mild cognitive impairment and Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 14: 222-32. PMID 18282320 DOI: 10.1017/S1355617708080260  0.76
2008 Li H, Wetten S, Li L, St Jean PL, Upmanyu R, Surh L, Hosford D, Barnes MR, Briley JD, Borrie M, Coletta N, Delisle R, Dhalla D, Ehm MG, Feldman HH, ... ... Gauthier S, et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Archives of Neurology. 65: 45-53. PMID 17998437 DOI: 10.1001/archneurol.2007.3  0.76
2008 Peters KR, Rockwood K, Black SE, Hogan DB, Gauthier SG, Loy-English I, Hsiung GY, Jacova C, Kertesz A, Feldman HH. Neuropsychiatric symptom clusters and functional disability in cognitively-impaired-not-demented individuals. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 16: 136-44. PMID 17928572 DOI: 10.1097/JGP.0b013e3181462288  0.76
2007 Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2314-24. PMID 18098298 DOI: 10.1002/mds.21844  0.76
2007 Aisen PS, Gauthier S, Vellas B, Briand R, Saumier D, Laurin J, Garceau D. Alzhemed: a potential treatment for Alzheimer's disease. Current Alzheimer Research. 4: 473-8. PMID 17908052 DOI: 10.2174/156720507781788882  0.76
2007 Vellas B, Andrieu S, Cantet C, Dartigues JF, Gauthier S. Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer? The Journal of Nutrition, Health & Aging. 11: 338-41. PMID 17653494  0.76
2007 Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. The Lancet. Neurology. 6: 734-46. PMID 17616482 DOI: 10.1016/S1474-4422(07)70178-3  0.76
2007 Belleville S, Chertkow H, Gauthier S. Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment. Neuropsychology. 21: 458-69. PMID 17605579 DOI: 10.1037/0894-4105.21.4.458  0.76
2007 Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1689-707; quiz 1837. PMID 17542011 DOI: 10.1002/mds.21507  0.76
2007 Blair M, Kertesz A, Davis-Faroque N, Hsiung GY, Black SE, Bouchard RW, Gauthier S, Guzman DA, Hogan DB, Rockwood K, Feldman H. Behavioural measures in frontotemporal lobar dementia and other dementias: the utility of the frontal behavioural inventory and the neuropsychiatric inventory in a national cohort study. Dementia and Geriatric Cognitive Disorders. 23: 406-15. PMID 17446701 DOI: 10.1159/000101908  0.76
2007 Rockwood K, Moorhouse PK, Song X, MacKnight C, Gauthier S, Kertesz A, Montgomery P, Black S, Hogan DB, Guzman A, Bouchard R, Feldman H. Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study. Journal of the Neurological Sciences. 252: 106-12. PMID 17189642 DOI: 10.1016/j.jns.2006.10.015  0.76
2006 Gagnon JF, Petit D, Fantini ML, Rompré S, Gauthier S, Panisset M, Robillard A, Montplaisir J. REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease. Sleep. 29: 1321-5. PMID 17068986  0.76
2006 Belleville S, Gilbert B, Fontaine F, Gagnon L, Ménard E, Gauthier S. Improvement of episodic memory in persons with mild cognitive impairment and healthy older adults: evidence from a cognitive intervention program. Dementia and Geriatric Cognitive Disorders. 22: 486-99. PMID 17050952 DOI: 10.1159/000096316  0.76
2006 Hsiung GY, Donald A, Grand J, Black SE, Bouchard RW, Gauthier SG, Loy-English I, Hogan DB, Kertesz A, Rockwood K, Feldman HH. Outcomes of cognitively impaired not demented at 2 years in the Canadian Cohort Study of Cognitive Impairment and Related Dementias. Dementia and Geriatric Cognitive Disorders. 22: 413-20. PMID 16966831 DOI: 10.1159/000095751  0.76
2006 Hudon C, Belleville S, Souchay C, Gély-Nargeot MC, Chertkow H, Gauthier S. Memory for gist and detail information in Alzheimer's disease and mild cognitive impairment. Neuropsychology. 20: 566-77. PMID 16938019 DOI: 10.1037/0894-4105.20.5.566  0.76
2006 Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, et al. Mild cognitive impairment. Lancet. 367: 1262-70. PMID 16631882 DOI: 10.1016/S0140-6736(06)68542-5  0.76
2006 Feldman HH, Gauthier S, Chertkow H, Conn DK, Freedman M, Chris M. Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: a conceptual summary. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 33: 6-26. PMID 16583717  0.76
2006 Peters KR, Rockwood K, Black SE, Bouchard R, Gauthier S, Hogan D, Kertesz A, Loy-English I, Beattie BL, Sadovnick AD, Feldman HH. Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics. Neurology. 66: 523-8. PMID 16505306 DOI: 10.1212/01.wnl.0000198255.84842.06  0.76
2006 Rockwood K, Black SE, Song X, Hogan DB, Gauthier S, MacKnight C, Vandorpe R, Guzman A, Montgomery P, Kertesz A, Bouchard RW, Feldman H. Clinical and radiographic subtypes of vascular cognitive impairment in a clinic-based cohort study. Journal of the Neurological Sciences. 240: 7-14. PMID 16212979 DOI: 10.1016/j.jns.2005.08.010  0.76
2005 McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, ... ... Gauthier S, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65: 1863-72. PMID 16237129 DOI: 10.1212/01.wnl.0000187889.17253.b1  0.76
2005 Feldman H, Gauthier S, Hecker J, Vellas B, Xu Y, Ieni JR, Schwam EM. Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial. International Journal of Geriatric Psychiatry. 20: 559-69. PMID 15920715 DOI: 10.1002/gps.1325  0.76
1996 Aubert I, Cécyre D, Gauthier S, Quirion R. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain. The Journal of Comparative Neurology. 369: 31-55. PMID 8723701 DOI: 10.1002/(SICI)1096-9861(19960520)369:1<31::AID-CNE3>3.0.CO;2-L  0.76
1995 Poirier J, Delisle MC, Quirion R, Aubert I, Farlow M, Lahiri D, Hui S, Bertrand P, Nalbantoglu J, Gilfix BM, Gauthier S. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America. 92: 12260-4. PMID 8618881 DOI: 10.1073/pnas.92.26.12260  0.76
1995 Aubert I, Rowe W, Meaney MJ, Gauthier S, Quirion R. Cholinergic markers in aged cognitively impaired Long-Evans rats. Neuroscience. 67: 277-92. PMID 7675169 DOI: 10.1016/0306-4522(95)00056-O  0.76
1994 Aubert I, Poirier J, Gauthier S, Quirion R. Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 2476-84. PMID 8182423  0.76
1992 Aubert I, Araujo DM, Cécyre D, Robitaille Y, Gauthier S, Quirion R. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. Journal of Neurochemistry. 58: 529-41. PMID 1729398  0.76
1992 Aubert I, Cécyre D, Gauthier S, Quirion R. Characterization and autoradiographic distribution of [3H]AF-DX 384 binding to putative muscarinic M2 receptors in the rat brain. European Journal of Pharmacology. 217: 173-84. PMID 1425938 DOI: 10.1016/0014-2999(92)90843-S  0.76
1990 Quirion R, Aubert I, Robitaille Y, Gauthier S, Araujo DM, Chabot JG. Neurochemical deficits in pathological brain aging: specificity and possible relevance for treatment strategies. Clinical Neuropharmacology. 13: S73-80. PMID 2093419  0.76
1989 Quirion R, Aubert I, Lapchak PA, Schaum RP, Teolis S, Gauthier S, Araujo DM. Muscarinic receptor subtypes in human neurodegenerative disorders: focus on Alzheimer's disease. Trends in Pharmacological Sciences. 80-4. PMID 2694529  0.76
Show low-probability matches.